MAX BioPharma reports on the anti-inflammatory effects of its oxysterol drug candidate, Oxy210, an orally available small molecule
different from steroids and NSAIDs.

Please follow the link for a copy of the manuscript. https://www.mdpi.com/1422-0067/23/10/5478